What is beta-thalassemia?
Beta-thalassemia (β-thalassemia) is the most common hemoglobin disorder found in the Mediterranean area and is estimated to affect 5 – 10 % of the Asian population. Affected individuals have low levels of hemoglobin leading to shortage of red blood cells (anemia), which can cause pale skin, weakness, fatigue, and more serious complications.
What causes β-thalassemia?
β-thalassemia is caused by mutations of the β-globin gene (HBB), resulting in defective (+) or absent (0) production of β-globin. A lack of β-globin leads to a reduced amount of functional hemoglobin and results in anemia. Depending on the clinical severity of the disease, it can be classified into β-thalassemia major, intermedia or minor.
How is β-thalassemia inherited?
Each person inherits 2 copies of the HBB gene, one from each parent. People with only 1 copy of the gene altered typically do not show any symptoms and are carriers of HBB gene mutations. However, some carriers have mild anaemia. If both parents are carriers, their offspring has a 25% chance of having a severe form of β-thalassemia (2 altered copies of HBB gene); a 50% chance of having a mild form of β-thalassemia (1 altered copy of HBB gene); and a 25% chance of being normal (no mutations). Children affected by severe forms of β-thalassemia would develop severe anaemia in infancy and would require frequent blood transfusion.
What is this test for?
This test detects the most common 21 mutations of the HBB gene (>95%) found in the Chinese and Southeast Asian population.
Who should consider this test?
Factor(s) known to affect results